TG Therapeutics Inc Dividends
The next dividend date for TG Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for TG Therapeutics Inc (TGTX)
More About TG Therapeutics Inc
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. The company was incorporated in 1993 and is based in Morrisville, North Carolina.
Owning TG Therapeutics Inc Stock on the Dividend Date
If you own TG Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of TG Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of TG Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying TG Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the TG Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning TG Therapeutics Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in TG Therapeutics Inc stock price from the dividend is already baked into TG Therapeutics Inc option prices.
That means the prices of call options that overlap the TG Therapeutics Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the TG Therapeutics Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of TG Therapeutics Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of TG Therapeutics Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More TG Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about TG Therapeutics Inc dividends or anything else related to the stock market.